Common Conditions of the Ear — Clinical Documentation Guide (2026)

This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive coding, clinical, and documentation guidance for common conditions of the ear — encompassing the external ear (H60–H62), middle ear and mastoid (H65–H75), inner ear (H80–H83), and other ear disorders including hearing loss (H90–H93). Content reflects FY2026 ICD-10-CM guidelines (effective October 1, 2025 – September 30, 2026) and incorporates current epidemiological, clinical, and CPT coding resources. Use this guide to ensure accurate diagnosis code assignment, appropriate CDI query triggers, and defensible documentation across all ear-related encounters.

🔍 1. Definition

Common conditions of the ear span four anatomical regions: the external ear (auricle, external auditory canal), the middle ear (tympanic membrane, ossicles, Eustachian tube, mastoid), the inner ear (cochlea, vestibular apparatus), and the auditory/vestibulocochlear nerve pathways. ICD-10-CM Chapter 8 (H60–H95) classifies diseases of the ear and mastoid process, and this guide covers the most clinically significant conditions encountered across primary care, ENT/otolaryngology, audiology, and urgent care settings.

Otitis externa (H60.x) is inflammation of the external auditory canal, ranging from acute diffuse infection (“swimmer’s ear”) to malignant (necrotizing) otitis externa — a life-threatening skull-base osteomyelitis predominantly affecting immunocompromised patients, as defined by StatPearls/NCBI.

Otitis media (H65–H67) encompasses nonsuppurative (serous, mucoid, allergic) and suppurative (acute, chronic tubotympanic, chronic atticoantral) middle ear inflammation. Otitis media is among the most common diagnoses in ambulatory pediatric care, per CDC antibiotic stewardship guidance.

Cholesteatoma (H71.x) is a destructive epidermal cyst of the middle ear or mastoid that erodes bone and surrounding structures, requiring surgical management. It must be distinguished from granulation tissue for accurate coding and CDI documentation.

Hearing loss (H90–H91) includes conductive, sensorineural, mixed, and age-related (presbycusis) forms as well as sudden idiopathic sensorineural hearing loss (SSNHL). Accurate laterality and type documentation directly affect risk adjustment tracking for dual-eligible Medicare beneficiaries.

Vestibular disorders (H81.x) — including Ménière’s disease and benign paroxysmal positional vertigo (BPPV) — generate significant diagnostic and procedural coding complexity due to overlapping symptomatology with central causes of vertigo.

🗂️ 2. Alternative Terminology

🩺 3. Signs & Symptoms

External Ear Conditions

• Otitis externa: Otalgia (often severe, worsened by tragal pressure or jaw movement), otorrhea, pruritus, external canal edema and erythema, possible conductive hearing loss from canal occlusion. Malignant OE presents with granulation tissue at the bony-cartilaginous junction, cranial nerve palsies (VII most common), and evidence of skull base involvement on CT/MRI per NCBI StatPearls.
• Impacted cerumen (H61.2x): Aural fullness, hearing loss, otalgia, tinnitus, vertigo.
• Perichondritis (H61.0x): Erythema, swelling, and tenderness of the auricle; fever; risk of auricular deformity (“cauliflower ear”) if untreated.

Middle Ear Conditions

• Acute suppurative OM (H66.0x): Rapid-onset otalgia, fever, bulging erythematous tympanic membrane, otorrhea with TM rupture, reduced hearing. Recurrent AOM = 3+ episodes in 6 months or 4+ in 12 months per AAP clinical practice guidelines.
• Otitis media with effusion (H65.x): Aural fullness, mild conductive hearing loss, crackling sounds; tympanic membrane may show air-fluid levels or retraction; often asymptomatic in children.
• Chronic suppurative OM (H66.1x–H66.3x): Persistent/recurrent painless otorrhea (tubotympanic) or foul-smelling discharge with attic perforation (atticoantral), gradual hearing loss, possible cholesteatoma.
• Cholesteatoma (H71.x): Foul-smelling otorrhea, conductive hearing loss, white keratinous debris in attic or postauricular area, possible vertigo/SNHL with inner ear erosion, facial nerve weakness (if eroding facial canal).
• Mastoiditis (H70.x): Postauricular erythema, tenderness, fluctuance; anterior/inferior ear displacement; fever; preceding or concurrent AOM. Complications include subperiosteal abscess, sigmoid sinus thrombosis, meningitis.

Inner Ear & Hearing Loss

• Ménière’s disease (H81.0x): Episodic vertigo (20 min – 12 hr), fluctuating low-frequency SNHL, tinnitus, aural fullness — the classic tetrad per AAO-HNS clinical practice guidelines.
• BPPV (H81.1x): Brief (seconds) rotational vertigo triggered by head position changes; positive Dix-Hallpike test; no hearing loss or tinnitus.
• Sudden SNHL (H91.2x): Unilateral hearing loss occurring within 72 hours, often awakening with hearing loss; may be accompanied by tinnitus and/or vertigo; requires urgent workup per AAO-HNS SSNHL guidelines.
• Presbycusis (H91.1x): Gradual bilateral symmetric high-frequency SNHL; difficulty understanding speech in noise; progressive over years.
• Otosclerosis (H80.x): Progressive conductive hearing loss (young adults, more common in females); Carhart’s notch on audiogram; normal tympanogram; positive Schwartze sign (flamingo pink blush through TM) in active cochlear otosclerosis.

🧭 4. Differential Diagnosis

📋 5. Clinical Indicators for Coders/CDI

🦴 6. Anatomy & Pathophysiology

Anatomical Overview

The ear is divided into three functional regions as described by NCBI StatPearls ear anatomy review:

• External ear: Auricle (pinna) and external auditory canal (EAC). The EAC is approximately 2.5 cm long, with a cartilaginous outer third and bony inner two-thirds. The EAC is lined with squamous epithelium and contains hair follicles and ceruminous glands. The EAC terminates at the tympanic membrane.
• Middle ear (tympanic cavity): An air-filled space containing the ossicular chain (malleus, incus, stapes) that mechanically amplifies and transmits sound from the tympanic membrane to the oval window. The Eustachian tube (pharyngotympanic tube) connects the middle ear to the nasopharynx, equalizing pressure and draining secretions. The mastoid process communicates with the middle ear via the aditus ad antrum.
• Inner ear: The cochlea (hearing) and vestibular labyrinth (balance — semicircular canals, utricle, saccule) embedded within the petrous temporal bone. The cochlea contains the organ of Corti with hair cells that transduce mechanical vibrations into neural impulses via the vestibulocochlear nerve (CN VIII).

Key Pathophysiological Mechanisms

• Otitis externa: Disruption of the acidic, cerumen-protective environment of the EAC (by moisture, mechanical trauma, or hearing aids) allows bacterial overgrowth — predominantly Pseudomonas aeruginosa (40%) and Staphylococcus aureus (30%). Malignant OE involves contiguous osteomyelitis of the skull base driven by P. aeruginosa in diabetic/immunocompromised hosts, per NCBI StatPearls malignant OE.
• Otitis media: Eustachian tube dysfunction (ETD) leads to negative middle ear pressure, fluid accumulation (OME), or bacterial superinfection (AOM). Common pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis. Recurrent/untreated AOM may progress to chronic suppurative OM with TM perforation and, in the atticoantral type, cholesteatoma formation.
• Cholesteatoma: Abnormal keratinizing squamous epithelium in the middle ear/mastoid; acquired type most commonly arises from Eustachian tube dysfunction and TM retraction pockets. Progressive bone erosion via osteoclast-activating enzymes (collagenases, IL-1, TNF-α) can destroy the ossicular chain, labyrinth, facial canal, and tegmen.
• Hearing loss: Conductive HL results from disorders affecting the outer/middle ear (OE, OM, TM perforation, otosclerosis, ossicular discontinuity). SNHL results from damage to the cochlear hair cells or CN VIII (noise exposure, ototoxicity, aging, viral infection). Mixed HL has both components. Sudden SNHL may reflect viral cochleitis, vascular ischemia, or perilymphatic fistula.
• Ménière’s disease: Endolymphatic hydrops (excess endolymph in the scala media of the cochlea and vestibular end-organs) disrupts the endocochlear potential, causing episodic dysfunction. The etiology is multifactorial (immune, genetic, vascular) per AAO-HNS Ménière’s clinical practice guideline.
• BPPV: Detached otoconia (calcium carbonate crystals) from the utricle migrate into semicircular canals (most commonly posterior), generating abnormal endolymph displacement during head movement and transient vertigo via ampullary hair cell stimulation.
• Otosclerosis: Abnormal bone remodeling of the otic capsule — normally resistant to bone turnover — leads to new spongy bone formation (otospongiosis) that fixes the stapes footplate in the oval window, impairing sound transmission and causing conductive/mixed HL.

💊 7. Medication Impact / Treatment

Pharmacological Treatments

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 8. ICD-10-CM Guidelines (FY2026)

The following guidelines from the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting (CMS) apply specifically to ear conditions in Chapter 8 (H60–H95):

General Coding Principles for Ear Conditions

• Laterality is mandatory: Nearly all H60–H93 codes include laterality in the final character (1 = right, 2 = left, 3 = bilateral, 0/9 = unspecified). Coders must capture laterality from the documented clinical record. Unspecified laterality codes are not acceptable when laterality is determinable from the record.
• Acuity specification: Otitis media codes require distinction between acute (H65.0x, H66.0x) and chronic (H65.2x–H65.4x, H66.1x–H66.3x) forms. Recurrent acute conditions require the “recurrent” 7th character when applicable.
• Sequencing with perforated TM: When suppurative otitis media causes or is associated with tympanic membrane perforation, code the OM first (H66.x) and assign an additional code for the TM perforation (H72.x). The reverse does NOT apply — H72.x is always coded as additional, never principal for OM-related encounters per AHA Coding Clinic guidance.
• Underlying disease coding (H67, H82, H94): When otitis media, vertigo, or hearing loss is manifestation of an underlying disease (e.g., measles, influenza, Wegener’s), code the underlying condition first (“code first” instruction), then H67.x, H82, or H94.x.
• Eustachian tube disorders (H68–H69): Eustachian tube obstruction (H68.x) and patulous Eustachian tube (H69.x) have distinct codes; each requires laterality. ETD is commonly an underlying cause of OME; both may be coded when documented.
• Cholesteatoma site specificity: H60.4x = external ear cholesteatoma (keratosis obturans); H71.0x = cholesteatoma of attic; H71.1x = cholesteatoma of tympanum; H71.2x = cholesteatoma of mastoid; H71.3x = diffuse cholesteatomatosis; H71.9x = unspecified middle ear. Surgical pathology report is the gold standard for specificity.
• Hearing loss coding (H90–H91): H90 distinguishes bilateral (H90.0, H90.3, H90.6), unilateral with normal contralateral hearing (H90.11/12, H90.41/42, H90.71/72), and unspecified (H90.2, H90.5, H90.8) forms. Presbycusis (H91.1x) is coded only when age-related hearing loss is documented as the etiology; do not default to presbycusis without physician documentation.
• Device complications (T85.6xx): Complications from cochlear implants, tympanostomy tubes, or ossicular prostheses are coded with T85.6xx (complications of internal prosthetic devices), followed by the specific complication code. Use 7th characters for encounter type: A = initial, D = subsequent, S = sequela.
• Noise-induced hearing loss (H83.3x): Requires laterality; code additionally Z77.010 (occupational exposure to noise) when applicable. Distinguish from ototoxic HL (H91.0x) by documentation of noise vs. drug exposure.

🔢 9. ICD-10-CM Code Set (FY2026)

External Ear — H60–H61

Middle Ear & Mastoid — H65–H75

Inner Ear — H80–H83

Hearing Loss & Other Ear Disorders — H90–H93

🔎 10. Indexing

When using the FY2026 ICD-10-CM Alphabetic Index, use these main terms and subterms:

• Otitis → externa (see subterms: acute, chronic, diffuse, malignant, hemorrhagic, swimmer’s) | media (see subterms: acute, chronic, suppurative, nonsuppurative, serous, mucoid, allergic, recurrent, tubotympanic, atticoantral, in diseases classified elsewhere)
• Cholesteatoma → attic (H71.0x) | middle ear NOS (H71.9x) | mastoid (H71.2x) | external ear (H60.4x)
• Mastoiditis → acute (subterms: with subperiosteal abscess, with complications) | chronic
• Perforation → tympanic membrane (see Perforation, tympanum) → attic, central, multiple, total, marginal
• Hearing loss → conductive (bilateral, unilateral right/left) | sensorineural | mixed | presbycusis | sudden | ototoxic (code first)
• Ménière’s disease / syndrome → H81.0x
• Vertigo → benign paroxysmal (BPPV) → H81.1x | central origin → H81.4 | labyrinthine → H83.x | Ménière’s → H81.0x
• Otosclerosis → oval window (nonobliterative / obliterative) | cochlear | other
• Tinnitus → H93.1x (with laterality)
• Cerumen → impacted → H61.2x
• Eustachian tube → obstruction → H68.x | patulous → H69.x
• Complication → cochlear implant → T85.6xx | prosthesis, ossicular → T85.6xx

🏥 11. CPT (2026)

Audiology / Vestibular Function Testing

New 2026 Hearing Device Services Codes (Replacing Deleted 92590–92595)

Surgical Procedures — Ear (ENT)

🧾 12. HCPCS (2026)

📚 13. AHA Coding Clinic (Recent Guidance)

💰 14. HCC / Risk Adjustment (v28)

The CMS-HCC Model V28 is fully operative for payment year 2026 (100% V28 as of January 1, 2026). Most ear conditions are non-HCC under V28, meaning they do not directly generate a risk adjustment factor (RAF) score. However, several ear diagnoses have important indirect risk adjustment implications.

✍️ 15. CDI Query Templates

🧑‍⚕️ 16. Treatments (Clinical)

External Ear Conditions

• Acute otitis externa: Topical antibiotic/steroid drops (ciprofloxacin/dexamethasone preferred); ear wick for significant canal edema; pain management (NSAIDs/acetaminophen); avoid water exposure; remove debris. Duration: 7–10 days.
• Malignant OE: 6–8 weeks anti-pseudomonal antibiotics (oral fluoroquinolone or IV); serial clinical/imaging assessment; hyperbaric oxygen as adjunct; debridement (CPT 69200–69205); surgical debridement for refractory/complicated cases; treat underlying immunocompromise per NCBI StatPearls.
• Impacted cerumen: Ceruminolytic agents (carbamide peroxide, docusate); irrigation (warm water syringe); manual microsuction (CPT 69210); ear canal irrigation — avoid if TM perforation suspected.

Middle Ear Conditions

• Acute suppurative OM: Observation (“watchful waiting”) appropriate for mild/moderate non-severe cases in children ≥2 years; amoxicillin 80–90 mg/kg/day (10 days <2 yr; 5–7 days ≥2 yr); amoxicillin-clavulanate for treatment failure or recent antibiotic exposure per AAP AOM guidelines.
• OME (chronic middle ear effusion): Watchful waiting ≤3 months; audiology assessment; autoinflation (Valsalva, Otovent); tympanostomy tube placement (CPT 69436) for persistent bilateral OME ≥3 months with hearing loss, recurrent AOM, or language delay per AAP OME clinical practice guideline.
• Chronic suppurative OM / cholesteatoma: Aural toilet and topical antibiotics for acute exacerbations; surgical tympanoplasty/mastoidectomy (CPT 69631–69646) is definitive for cholesteatoma — complete surgical excision required to prevent recurrence and complications. Annual surveillance imaging/examination for recurrence.
• Mastoiditis: IV antibiotics (ampicillin-sulbactam or ceftriaxone); myringotomy with culture; cortical mastoidectomy (CPT 69501–69505) for subperiosteal abscess or failed medical therapy; intracranial complications require neurosurgical collaboration.

Inner Ear / Hearing Loss

• Ménière’s disease: Conservative: low-sodium diet (<2g/day), diuretics, stress reduction; intratympanic steroids (CPT 69801) for vertigo control; intratympanic gentamicin for disabling vertigo (ablative, risks residual hearing loss); endolymphatic sac surgery (CPT 69805–69806); labyrinthectomy/vestibular nerve section for refractory cases per AAO-HNS Ménière’s guideline.
• BPPV: Canalith repositioning — Epley maneuver (90% success rate for posterior canal); Semont liberatory maneuver; Brandt-Daroff exercises for home rehabilitation; vestibular rehabilitation therapy (VRT). Surgical canal occlusion for refractory cases (rare).
• Sudden SNHL: Urgent evaluation; oral steroids (prednisone 1 mg/kg/day × 10–14 days) — initiate within 2 weeks of onset; intratympanic dexamethasone as salvage for inadequate oral steroid response; hyperbaric oxygen (adjunct evidence); MRI with gadolinium to exclude retrocochlear pathology per AAO-HNS SSNHL guideline.
• Otosclerosis: Hearing aid (conservative management); stapedectomy/stapedotomy (CPT 69660–69661) — highly effective for conductive component; cochlear implant for far-advanced cochlear otosclerosis with profound SNHL (CPT 69930 + L8614).
• Presbycusis/SNHL (rehabilitation): Hearing aid evaluation and fitting (CPT 92628–92634 + HCPCS V5xxx); assistive listening devices; aural rehabilitation; cochlear implant for severe-profound bilateral SNHL when hearing aids no longer provide benefit.

🎓 17. Patient Education / Summary

Key Messages for Patient-Facing Documentation

Ear conditions span a wide spectrum — from common infections like swimmer’s ear and middle ear infections to complex conditions like cholesteatoma, hearing loss, and balance disorders. Early diagnosis and accurate treatment documentation protect patients and ensure they receive appropriate care coverage.

Prevention & Self-Care

• Prevent swimmer’s ear: Dry ears thoroughly after water exposure; use a hair dryer on low setting; tilting head to drain water; avoid cotton swabs in the ear canal (push wax deeper, may cause trauma).
• Protect hearing: Use hearing protection (earplugs, earmuffs) in high-noise environments (>85 dB); limit headphone volume (60/60 rule: 60% volume, 60 min/day maximum); avoid ototoxic medications when alternatives exist.
• Manage ear infections early: Seek medical care for ear pain, fever, and discharge; complete prescribed antibiotic courses; follow up for resolution to avoid progression to chronic disease.
• Balance/vertigo safety: Patients with active vertigo should avoid driving, heights, and operating machinery; fall prevention strategies are critical, particularly for elderly patients with Ménière’s disease or BPPV.

Hearing Aid & Cochlear Implant Information

Patients with significant hearing loss should understand that:

• Hearing aids require a proper audiologic evaluation and fitting (new 2026 CPT codes 92628–92634 standardize this process)
• Cochlear implants are covered under Medicare Part B (CPT 69930 + HCPCS L8614) for patients meeting audiologic and medical candidacy criteria
• Bone-anchored hearing aids (BAHA/Osia) are available for conductive/mixed HL or unilateral deafness (HCPCS L8690)
• Hearing aids are NOT covered under traditional Medicare Part B; Medicare Advantage plans may offer hearing benefits per ASHA payer guidance

When to Seek Urgent Care

• Sudden hearing loss in one or both ears (SSNHL) — treat as a medical emergency; evaluation within 24–72 hours is critical for best outcomes
• Severe ear pain with fever and postauricular swelling (possible mastoiditis)
• Facial weakness/paralysis with ear symptoms (possible cholesteatoma or malignant OE with CN VII involvement)
• Vertigo with sudden severe headache, vision changes, or neurological symptoms (central cause requiring immediate evaluation)
• Ear pain with diabetes or compromised immune system (possible malignant OE)

Coding Summary for Documentation Completeness

For every ear-related encounter, clinician documentation should include:

1. Laterality — which ear(s) are affected
2. Acuity — acute vs. chronic; recurrent if applicable
3. Specific diagnosis — not just “ear infection” but the type (serous OME, acute suppurative OM, cholesteatoma, etc.)
4. Hearing status — documented audiologic findings; type of hearing loss if present
5. Associated conditions — diabetes, immunocompromise, prior surgeries, device presence
6. Treatment plan — medical vs. surgical; antibiotic type if prescribed; procedure performed

Complete documentation ensures accurate ICD-10-CM code assignment, supports medical necessity for procedures, and enables appropriate reimbursement under the FY2026 ICD-10-CM guidelines.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)